GAS5 and myeloid sarcoma: In the MS cohorts, miR-137 was significantly downregulated ~25-fold, while the level of growth arrest-specific transcript (GAS5), a ceRNA targeting miR-137-3p, was upregulated two-fold, and MS risk was associated with specific variants of miR-137 and GAS5 [108].